Citigroup
KLDO

Citigroup’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Citigroup’s Portfolio KLDO Stock Details KLDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,442
Closed -$2K – 6919
2022
Q1 		$2K Sell
1,442
-3,527
-71% -$6.29K ﹤0.01% 6132
2021
Q4 		$12K Buy
4,969
+436
+10% +$1.77K ﹤0.01% 5536
2021
Q3 		$25K Buy
4,533
+972
+27% +$6.03K ﹤0.01% 5146
2021
Q2 		$26K Buy
3,561
+1,668
+88% +$11.8K ﹤0.01% 5167
2021
Q1 		$15K Sell
1,893
-1,432
-43% -$15.6K ﹤0.01% 5421
2020
Q4 		$30K Buy
3,325
+1,897
+133% +$15.6K ﹤0.01% 6401
2020
Q3 		$16K Sell
1,428
-59,093
-98% -$409K ﹤0.01% 6347
2020
Q2 		$449K Buy
60,521
+56,186
+1,296% +$377K ﹤0.01% 4356
2020
Q1 		$27K Buy
4,335
+1,886
+77% +$12.3K ﹤0.01% 6496
2019
Q4 		$12K Buy
2,449
+1,599
+188% +$10.2K ﹤0.01% 7157
2019
Q3 		$6K Sell
850
-564
-40% -$4.9K ﹤0.01% 7299
2019
Q2 		$16K Sell
1,414
-968
-41% -$14.1K ﹤0.01% 7174
2019
Q1 		$35K Buy
+2,382
New +$32.8K ﹤0.01% 6631

Other funds holding KLDO

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Citigroup's KLDO Position: Q2 2022 in Review

Citigroup sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 1,442 shares — an estimated $2K sold.

Citigroup first reported a position in KLDO in Q1 2019 and held it in 13 quarters. The position peaked at $449K in Q2 2020. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

  • Citigroup reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Citigroup sold 1,442 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $2K.
  • Citigroup first reported a position in Kaleido Biosciences, Inc. Common Stock in Q1 2019 and held it in 13 quarters.
  • Citigroup's Kaleido Biosciences, Inc. Common Stock position peaked at $449K in Q2 2020.
  • 3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.